Synergistic Molecular Imaging and Therapy System

A novel system integrating multivalent molecular imaging and/or therapy with AI, IoT, and blockchain technologies to enable real-time monitoring and personalized treatment.

The original patent disclosed a multivalent molecular imaging and/or targeted drug delivery method, but it lacked real-time monitoring and tracking capabilities. The new inventive concept addresses this limitation by incorporating AI, IoT, and blockchain technologies to provide a more comprehensive and efficient system.

The system comprises a multivalent molecule with multiple targeting moieties, each binding to a distinct biomarker. The molecule is integrated with an IoT-enabled device for real-time monitoring of its interaction with the biomarkers. A blockchain-based tracking module ensures secure and transparent data storage and sharing. AI-powered computational models analyze the molecule's interaction with the biomarkers and predict optimal spacer lengths for personalized treatment. The system enables real-time monitoring, personalized treatment, and improved patient outcomes.

The new claims introduce the integration of AI, IoT, and blockchain technologies with the original multivalent molecular imaging and/or therapy concept, providing a novel and non-obvious solution for real-time monitoring and personalized treatment.

Alternative embodiments include using different AI algorithms, IoT devices, or blockchain platforms. Variations may include integrating the system with other medical devices or using different types of biomarkers.

The Synergistic Molecular Imaging and Therapy System has significant commercial potential in the healthcare industry, particularly in the fields of cancer treatment, personalized medicine, and medical imaging. The system's real-time monitoring and tracking capabilities make it an attractive solution for hospitals, research institutions, and pharmaceutical companies.